Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
0.00%
)
US TECH 100
24,066.80
(
0.21%
)
Dow Jones
46,946.41
(
0.00%
)
Brent Oil
99.70
(
1.42%
)
Bitcoin
73,754.59
(
-1.46%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Spitz

Send PM Follow Ignore
Followers 0
Posts 5
Boards Moderated 0
Alias Born 02/05/2006

Spitz

Re: DewDiligence post# 55895

Monday, 12/10/2007 10:17:33 AM

Monday, December 10, 2007 10:17:33 AM

Post# of 257251
Both Factor Xa inhibitors are also being tested in ACS. They are both in Phase II. For example, apixaban:

http://clinicaltrials.gov/show/NCT00313300

Also, Dabigatran RE-DEEM trial is 6 month treatment. I assume that Momenta's drug is in hospital treatment since it is IV - so do you consider the two drugs competitors?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now